RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tanke Biosciences Stock

Tanke Biosciences Stocks 2024

Tanke Biosciences Stocks

13.32 M

Ticker

TNBI

ISIN

US87583Y1073

In 2024, Tanke Biosciences had 13.32 M outstanding stocks, a 1.84% change from the 13.08 M stocks in the previous year.

The Tanke Biosciences Stocks history

YEARNUMBER OF STOCKS (undefined USD)
201213.32
201113.08
201010.76
20090.4
20080.4
20070.4

Tanke Biosciences shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Tanke Biosciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Tanke Biosciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Tanke Biosciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Tanke Biosciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Tanke Biosciences Aktienanalyse

What does Tanke Biosciences do?

Tanke Biosciences Corp is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune system disorders. The company was founded in 2016 and is headquartered in Beijing, China. Tanke Biosciences aims to provide patients worldwide access to high-quality medicines and improve the chances of recovery for people with serious illnesses. The business model of Tanke Biosciences is based on the discovery and development of new drugs that can be used in clinics and hospitals. The company's main focus is the research of protease inhibitors, molecules that inhibit the activity of enzymes and therefore reduce inflammation. The company has acquired world-leading expertise in the development of protease inhibitors and is one of the most promising companies in the industry in this area. Tanke Biosciences has various divisions in which the company operates. One of the most important divisions is the development of drugs for the treatment of autoimmune diseases. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the protein DPP4. DPP4 is involved in the regulation of the immune system and plays an important role in the development of autoimmune diseases such as diabetes or rheumatoid arthritis. The DPP4 inhibitors of Tanke Biosciences are promising candidates for improved therapy of these diseases. Another division of Tanke Biosciences is the research of cancer therapies. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the enzyme Cathepsin K. Cathepsin K is involved in the development and spread of malignant tumors and thus plays an important role in the fight against cancer. The Cathepsin K inhibitors of Tanke Biosciences are promising for the development of new cancer therapies. Tanke Biosciences also offers other products and services that serve the research of molecular drugs. These include, for example, peptide libraries that researchers can use to identify new drugs. In addition, the company offers comprehensive research services to support customers in drug discovery and development. Overall, Tanke Biosciences is an innovative biopharmaceutical company specializing in the discovery and development of new drugs for the treatment of autoimmune diseases, cancer, and other immune system disorders. With its products and services, the company makes an important contribution to improving the health of people worldwide. Tanke Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Tanke Biosciences's Shares Outstanding

Tanke Biosciences's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Tanke Biosciences’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Tanke Biosciences’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Tanke Biosciences’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Tanke Biosciences stock

How many stocks are there of Tanke Biosciences?

The current number of stocks of Tanke Biosciences is 13.32 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Tanke Biosciences are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Tanke Biosciences evolved in recent years?

The number of shares of Tanke Biosciences has increased by 1.84% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Tanke Biosciences as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Tanke Biosciences?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Tanke Biosciences pay?

Over the past 12 months, Tanke Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tanke Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Tanke Biosciences?

The current dividend yield of Tanke Biosciences is .

When does Tanke Biosciences pay dividends?

Tanke Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tanke Biosciences?

Tanke Biosciences paid dividends every year for the past 0 years.

What is the dividend of Tanke Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tanke Biosciences located?

Tanke Biosciences is assigned to the '-' sector.

Wann musste ich die Aktien von Tanke Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tanke Biosciences from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Tanke Biosciences pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Tanke Biosciences in the year 2023?

In the year 2023, Tanke Biosciences distributed 0 USD as dividends.

In which currency does Tanke Biosciences pay out the dividend?

The dividends of Tanke Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tanke Biosciences

Our stock analysis for Tanke Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tanke Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.